medigraphic.com
ISSN 3061-8142 (Electronic)

2026, Number S1

<< Back Next >>

Rev Mex Anest 2026; 49 (S1)

Monitoring neurodevelopment in post-fetal surgery infants for myelomeningocele

Canul-Euan AA

Language: Spanish
References: 10
Page: 296-298
PDF size: 727.60 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Lara-Ávila L, Martínez-Rodríguez M, Villalobos-Gómez R, Gámez-Varela A, Aguilar-Avidales K, López-Briones H, et al. Espina bífidaabierta. Diagnóstico, pronóstico y opciones de corrección intrauterina porcirugía fetal abierta y fetoscópica. Ginecol Obstet Mex. 2022;90:73-83.

  2. Koch VH, Lopes MT, Furusawa E, Vaz K, Barroso U. Multidisciplinarymanagement of people with spina bifida across the lifespan. PediatrNephrol. 2024;39:681-697.

  3. Adzick NS, Thom EA, Spong CY, Brock JW, Burrows PK, JohnsonMP, et al. A randomized trial of prenatal versus postnatal repair ofmyelomeningocele. N Engl J Med. 2011;364:993-1004.

  4. Farmer DL, Thom EA, Brock JW, Burrows PK, Johnson MP, Howell LJ,et al. The Management of Myelomeningocele Study: full cohort 30-monthpediatric outcomes. Am J Obstet Gynecol. 2018;218:256.e1-256.e13.

  5. Houtrow AJ, Thom EA, Fletcher JM, Burrows PK, Adzick NS, ThomasNH, et al. Prenatal repair of myelomeningocele and school-age functionaloutcomes. Pediatrics. 2020;145:e20191544.

  6. Siahaan AMP, Susanto M, Lumbanraja SN, Ritonga DH. Long-termneurological cognitive, behavioral, functional, and quality of lifeoutcomes after fetal myelomeningocele closure: a systematic review.Clin Exp Pediatr. 2023;66:38-45.

  7. Kabagambe SK, Jensen GW, Chen YJ, Vanover MA, Farmer DL.Fetal surgery for myelomeningocele: a systematic review and metaanalysisof outcomes in fetoscopic versus open repair. Fetal Diagn Ther.2018;43:161-174.

  8. Cortes MS, Belfort MA, Whitehead WE, Espinoza J, ShamshirsazAA, Nassr AA, et al. Neurodevelopmental outcomes after fetoscopicmyelomeningocele repair. J Pediatr. 2025;281:114472.

  9. Farmer DL, Kumar P, Reynolds E, Lee SY, Powne AB, Pivetti CD,et al. Feasibility and safety of cellular therapy for in-utero repair ofmyelomeningocele (CuRe Trial): a first-in-human, phase 1, singlearmstudy. Lancet. 2026;407(10531):867-875. doi: 10.1016/S0140-6736(25)02466-3.

  10. Jobe AH. Fetal surgery for myelomeningocele. N Engl J Med.2002;347:230-231.




2020     |     www.medigraphic.com